Therapeutic combination of free-radical scavenger or...

Details Therapeutic combination of free-radical scavenger or... Therapeutic combination of free-radical scavenger or...

A - Human Necessities

61

K

167/103.1, 167/1

A61K 38/19 (2006.01) A61K 38/20 (2006.01) A61K 38/21 (2006.01)

Patent

CA 1321349

Abstract of the Disclosure Damage to cells, tissue and other body parts in a mammalian host may be treated by using a lymphokine or cytotoxin in conjunction with at least one biological modifier, which may be a free radical scavenger or a metabolic inhibitor. The lymphokine or cytotoxin is preferably tumor necrosis factor and the biological modifier is preferably uric acid, buthionine sulphoximine, vitamin C, aspirin, or nordihydroguaiaretic acid. Such a combination may be used to treat, for example, cancer, infectious diseases, and damage caused by radiation therapy, high oxygen tension, and chemotherapy.

551719

Affiliated with

Also associated with

Rating

Therapeutic combination of free-radical scavenger or... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Therapeutic combination of free-radical scavenger or..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapeutic combination of free-radical scavenger or... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1222746